In 2020, Oneness Biotech and LEO Pharma partnered on a 570 million U.S. dollar respiratory diseases deal, while Moderna and Vertex partnered on a 380 million U.S. dollar respiratory deal in the same year. This statistic illustrates select respiratory disease deals by biopharmaceutical companies worldwide in 2020, by deal value.
Select respiratory disease deals by biopharmaceutical companies worldwide in 2020, by value
(in million U.S. dollars)
Partners 1 and 2
Value in million U.S. dollars
Oneness Biotech, LEO Pharma
570
Moderna Therapeutics, Vertex Pharmaceuticals
380
Curadev Pvt., Bayer AG
268
aTyr Pharma, Kyorin Pharmaceutical
175
Pulmatrix, Johnson and Johnson (Lung Cancer Initiative) 02/
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Nature. (December 1, 2020). Select respiratory disease deals by biopharmaceutical companies worldwide in 2020, by value (in million U.S. dollars) [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/1240172/leading-respiratory-disease-deals-biopharma-companies-by-value/
Nature. "Select respiratory disease deals by biopharmaceutical companies worldwide in 2020, by value (in million U.S. dollars)." Chart. December 1, 2020. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1240172/leading-respiratory-disease-deals-biopharma-companies-by-value/
Nature. (2020). Select respiratory disease deals by biopharmaceutical companies worldwide in 2020, by value (in million U.S. dollars). Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1240172/leading-respiratory-disease-deals-biopharma-companies-by-value/
Nature. "Select Respiratory Disease Deals by Biopharmaceutical Companies Worldwide in 2020, by Value (in Million U.S. Dollars)." Statista, Statista Inc., 1 Dec 2020, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1240172/leading-respiratory-disease-deals-biopharma-companies-by-value/
Nature, Select respiratory disease deals by biopharmaceutical companies worldwide in 2020, by value (in million U.S. dollars) Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1240172/leading-respiratory-disease-deals-biopharma-companies-by-value/ (last visited November 10, 2024)
Select respiratory disease deals by biopharmaceutical companies worldwide in 2020, by value (in million U.S. dollars) [Graph], Nature, December 1, 2020. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/1240172/leading-respiratory-disease-deals-biopharma-companies-by-value/
